Resolves Yes if Settles to the outcome the underlying source market resolves to.
Outcome verified from gamma-api.polymarket.com.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Anduril's current valuation is far below $150B, and only about 5.5 months remain in 2026. A jump to $150B would require an unprecedented contract or IPO valuation, far exceeding defense industry peers. Therefore, the likelihood is very low.
